Docoh
Loading...

121 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q2
EX-31.1
PCSA Processa Pharmaceuticals Inc
12 Aug 21
Quarterly report
4:01pm
as of, and for, the periods presented in this report; 4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined
10-Q
2021 Q2
EX-31.2
PCSA Processa Pharmaceuticals Inc
12 Aug 21
Quarterly report
4:01pm
as of, and for, the periods presented in this report; 4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined
UPLOAD
PCSA Processa Pharmaceuticals Inc
5 Jul 21
Letter from SEC
8:00pm
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
shall remain responsible for the performance of its obligations under this Agreement, regardless of whether Processa may have delegated those … of this Agreement, including the requirements of ARTICLE V, Processa (or its Affiliates or Sublicensees) shall control and be solely responsible
10-Q
2021 Q1
EX-31.1
PCSA Processa Pharmaceuticals Inc
13 May 21
Quarterly report
4:30pm
and cash flows of the registrant as of, and for, the periods presented in this report; 4. I am responsible for establishing and maintaining
10-Q
EX-31.2
qsmqmr m8
13 May 21
Quarterly report
4:30pm
DEF 14A
pmicx ng9m
22 Apr 21
Definitive proxy
2:00pm
10-K/A
anhze00rqoq7k
7 Apr 21
Annual report (amended)
4:23pm
UPLOAD
yfn1nn
4 Apr 21
Letter from SEC
8:00pm
10-K
EX-31.2
6mpwn kg6oi9xl6cc7ru
24 Mar 21
Annual report
8:00pm
10-K
EX-31.1
z1gkngiii0 8w51
24 Mar 21
Annual report
8:00pm
10-K
v4kx5mhicrf nd
24 Mar 21
Annual report
8:00pm
8-K
EX-10.1
jdhh d3s90up
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-99.1
8inm bsl6r
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.2
c604uchp
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.3
8ior algcmmby
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
10-Q
EX-31.1
2quqbtm bkr9ko7vkdej
12 Nov 20
Quarterly report
4:01pm
10-Q
EX-31.2
kb0ryf qr619i67nt1
12 Nov 20
Quarterly report
4:01pm
424B4
xwev0h3335x82sdopbo
5 Oct 20
Prospectus supplement with pricing info
4:16pm
S-1/A
sxzon
30 Sep 20
IPO registration (amended)
4:06pm